Bachtel Nathaniel D, Beckerle Greta A, Mota Talia M, Rougvie Miguel de Mulder, Raposo Rui André Saraiva, Jones R Brad, Nixon Douglas F, Apps Richard
Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.
AIDS Res Hum Retroviruses. 2019 Jan;35(1):108-111. doi: 10.1089/AID.2018.0162. Epub 2018 Oct 16.
Much has been learnt from the functions of host restriction factors during acute and chronic HIV-1 infection, but far less is known about their role in HIV-1-infected individuals in which viral load is stably suppressed with antiretroviral therapy (ART). In this study transcriptional expression of 42 host restriction factors was determined for memory CD4+ T cells sorted from 10 uninfected and 21 HIV-1-infected individuals, treated with suppressive ART and for which the viral reservoir was quantified. No significant associations were observed between restriction factor expression and HIV-1 reservoir size, quantified by measurement of HIV-1 Gag DNA using droplet digital polymerase chain reaction, and by measurement of replication-competent inducible virus using quantitative viral outgrowth assays. Expression of eight of the restriction factors differed significantly, and with a false discovery rate of <10%, between ART-suppressed and uninfected individuals. APOBEC3G, ISG15, LGALS3BP, RNASEL, and MX2 were upregulated in the ART-suppressed individuals, likely because of increased levels of immune activation observed in virally suppressed compared with uninfected individuals. In contrast CDKN1A, TRIM11, and BRD4 were expressed at lower levels in ART-suppressed than uninfected individuals. This suggests perturbation of the CD4+ memory T cell compartment, in which a viral reservoir persists in HIV-1-infected individuals with effective ART. Modulation of restriction factor expression, or overrepresentation of cell subsets that intrinsically express these restriction factors at lower levels could result in the distinct expression of restriction factors observed in treated infected individuals.
关于宿主限制因子在急性和慢性HIV-1感染过程中的功能,我们已经了解很多,但对于它们在接受抗逆转录病毒疗法(ART)后病毒载量得到稳定抑制的HIV-1感染者中的作用,我们所知甚少。在本研究中,我们测定了从10名未感染个体和21名接受抑制性ART治疗且已对病毒储存库进行定量的HIV-1感染者中分选出来的记忆性CD4+ T细胞中42种宿主限制因子的转录表达。通过使用液滴数字聚合酶链反应测量HIV-1 Gag DNA以及使用定量病毒生长测定法测量具有复制能力的诱导性病毒,对限制因子表达与HIV-1储存库大小之间未观察到显著关联。在接受ART抑制的个体与未感染个体之间,8种限制因子的表达存在显著差异,且错误发现率<10%。在接受ART抑制的个体中,载脂蛋白B mRNA编辑酶催化多肽样3G(APOBEC3G)、ISG15、3-半乳糖苷结合蛋白(LGALS3BP)、核糖核酸酶L(RNASEL)和Mx2上调,这可能是因为与未感染个体相比,在病毒抑制状态下观察到免疫激活水平升高。相比之下,细胞周期蛋白依赖性激酶1A(CDKN1A)、TRIM11和溴结构域蛋白4(BRD4)在接受ART抑制的个体中的表达水平低于未感染个体。这表明在接受有效ART治疗的HIV-1感染者中,CD4+记忆T细胞区室受到干扰,其中病毒储存库持续存在。限制因子表达的调节,或固有表达这些限制因子水平较低的细胞亚群的过度存在,可能导致在接受治疗的感染个体中观察到限制因子的不同表达。